-

03:19:15 PM

RCEL Stock News

RCEL - AVITA Medical Inc

01/28/21 4:01 PM

Nasdaq : RCEL

earnings

AVITA Medical to Announce Fiscal Second Quarter 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,

RHEA-AI

neutral

01/12/21 8:00 AM

Nasdaq : RCEL

earnings

AVITA Medical Announces Preliminary Fiscal Second Quarter 2021 Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,

RHEA-AI

neutral

12/28/20 5:00 PM

Nasdaq : RCEL

conferences

AVITA Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,

RHEA-AI

neutral

12/15/20 8:00 AM

Nasdaq : RCEL

RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH),

RHEA-AI

positive

12/01/20 8:00 AM

Nasdaq : RCEL

management

AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet

RHEA-AI

neutral

11/18/20 4:01 PM

Nasdaq : RCEL

conferences

AVITA Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that

RHEA-AI

neutral

11/10/20 4:01 PM

Nasdaq : RCEL

earnings

AVITA Therapeutics Reports First Quarter 2021 Financial Results

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported

RHEA-AI

neutral

11/10/20 8:00 AM

Nasdaq : RCEL

AVITA Therapeutics, Inc.: Results of 2020 Annual Meeting of Shareholders

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH) ( Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for

RHEA-AI

very positive

11/09/20 8:00 AM

Nasdaq : RCEL

AVITA Therapeutics and the Houston Methodist Research Institute Enter into Collaboration to Explore Novel Approaches for Skin Rejuvenation

RHEA-AI

very positive

11/05/20 10:30 PM

Nasdaq : RCEL

AVITA Therapeutics, Inc. Announces Executive Change

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet

RHEA-AI

neutral

Prev 1 2 3 4 Next

RCEL Data:

IndustrySurgical and Medical Instrument Manufacturing
Websiteavitamedical.com
Security nameAVITA Medical Inc
Issue typecs
SectorManufacturing
Sic code3841
Employees2020
Tags
- Health Technology
- Biotechnology
- Medical Specialties

RCEL Description:

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical's patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient's own skin. The medical devices work by preparing a RES® REGENERATIVE EPIDERMAL SUSPENSION, an autologous suspension comprised of the patient's skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment.